May 15, 2026 — The Blockchain Futurist Conference is set to return to Toronto on July 21-22, taking the spotlight at its flagship venue, Rebel Entertainment Complex and Cabana Pool Bar. The ninth edition conference, part of Emerald Expositions’ global portfolio, is expanding its international reach while continuing to focus on high-value networking and business development for founders, executives, investors, policymakers, and innovators.
May 15, 2026 — A2Z Cust2Mate Solutions Corp. (NASDAQ: AZ) reported first-quarter 2026 results reflecting continued transition from pilot programs to scaled commercial deployment, with contracted backlog expanding to approximately $195 million representing more than 19,000 smart carts scheduled for deployment through 2027.
May 15, 2026 — Oncotelic Therapeutics (OTCQB: OTLC) was featured in a NetworkNewsAudio audio press release focused on emerging opportunities in central nervous system drug delivery, highlighting the challenges posed by the blood-brain barrier and the company’s efforts to advance technologies designed to overcome those limitations. The editorial also noted Oncotelic’s recent strategic monetization agreement with Lunai Bioworks involving its N2B delivery system, supporting initiatives in biodefense and Alzheimer’s disease treatment.
May 15, 2026 — This article has been disseminated on behalf of SPARC AI Inc. and may include paid advertising.
May 15, 2026 — This article has been disseminated on behalf of MindBio Therapeutics Corp. and may include paid advertising.
May 15, 2026 — This article has been disseminated on behalf of SureNano Science Ltd. and may include paid advertising.
May 15, 2026 — This article has been disseminated on behalf of Trilogy Metals Inc. and may include paid advertising.
May 15, 2026 — Oncotelic Therapeutics (OTCQB: OTLC) reported first-quarter 2026 financial results and a corporate update highlighting continued advancement across its oncology, AI-enabled drug development and advanced drug delivery initiatives, including progress within its Sapu Nano joint venture and nose-to-brain CNS delivery platform. The company also said it maintained the previously established approximately $388 million fair value of its 45% ownership interest in GMP Biotechnology as of March 31, 2026, while continuing to pursue capital-efficient growth across its diversified biotechnology platform.
May 15, 2026 — This article has been disseminated on behalf of McEwen Inc. and may include paid advertising.
May 15, 2026 — Safe Pro Group (NASDAQ: SPAI) reported record first-quarter 2026 revenue of $1. 22 million, a 560% increase from the prior-year period, driven by commercialization of its AI-powered edge computing and drone imagery analysis solutions for defense applications.
May 15, 2026 — American farmers are facing a brutal combination of erratic weather, climbing input costs, and margins so thin that one bad season can erase a year’s profit. New RMI research shows wind and solar income rivaling major farm commodities in some states, a development with real implications for cash-strapped farming communities.
May 15, 2026 — The release of the long-awaited CLARITY Act has intensified debate in Washington over how the U. S.
May 15, 2026 — China’s electric vehicle industry is now facing growing pressure from Western countries, especially Europe and the United States. Many analysts are comparing this situation to what happened to Japan’s car industry in the 1980s, when American leaders restricted Japanese car exports to protect local automakers.
May 15, 2026 — On Wednesday, shares of Ford Motor jumped 13%, a stock movement that was its best daily performance in nearly half a decade. This jump came as the company announced that it was venturing into energy storage as a way to utilize the factory space that had previously been allocated to making EV batteries.
May 15, 2026 — Annovis Bio (NYSE: ANVS) reported first-quarter 2026 business and financial results, highlighting continued advancement of its clinical-stage neurodegenerative disease programs, including 85% enrollment in its pivotal Phase 3 Alzheimer’s disease trial and closure of enrollment to new participants after reaching sufficient screening levels to meet enrollment goals. The company also reported progress in its Parkinson’s disease open-label extension study, which has reached 40% enrollment, alongside new biomarker initiatives and AI-powered digital monitoring, as Annovis continues advancing buntanetap toward potential regulatory submission.
May 15, 2026 — NanoViricides, Inc. (NYSE American: NNVC) announced the filing of its quarterly report for the period ended March 31, 2026, highlighting continued advancement of its broad-spectrum antiviral candidate NV-387 toward Phase II clinical development for MPox in the Democratic Republic of Congo, where regulatory approval for the trial has already been obtained.
May 15, 2026 — SOLOWIN HOLDINGS (NASDAQ: AXG) announced that its AX Coin stablecoin subsidiary has signed a non-binding memorandum of understanding with INFINIOS to develop regulated wallet infrastructure and digital payment solutions aimed at accelerating stablecoin adoption across the Gulf region. The collaboration is expected to integrate AX Coin into INFINIOS’ payments infrastructure, enabling compliant custodial and non-custodial wallet solutions, multi-currency virtual accounts, fiat on/off ramps, and real-time cross-border settlement capabilities for institutional clients.
May 15, 2026 — NanoViricides, Inc. (NYSE American: NNVC) announced a securities purchase agreement with a single institutional investor for a registered direct offering expected to generate approximately $2 million in gross proceeds through the sale of 1,333,334 common shares, or pre-funded warrants in lieu thereof, along with accompanying warrants to purchase an equal number of common shares.
May 15, 2026 — LIXTE Biotechnology Holdings (NASDAQ: LIXT), announced the filing of its first-quarter 2026 Form 10-Q, highlighting continued advancement of its lead oncology candidate, LB-100, including expansion of its ovarian cancer trial following favorable safety findings in combination with immunotherapy. The company also cited continued growth at its recently acquired Liora Technologies Europe subsidiary as it pursues broader strategic expansion to strengthen its oncology pipeline and treatment development capabilities.
May 15, 2026 — Nutriband (NASDAQ: NTRB) announced that its wholly owned subsidiary, Active Intelligence, will participate in the June 2026 ECRM conference, where it plans to showcase its expanding portfolio of wellness, recovery and performance-focused consumer products to buyers from major retail, pharmacy and healthcare organizations. The company will feature its existing AI Tape line and introduce new products including AI Performance Tape, AI Energy Patches and AI Sleep as it seeks to expand retail partnerships and distribution opportunities.
